AQR CAPITAL MANAGEMENT LLC

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 1167557 Greenwich, CT

Position in RIGL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,882,213

+$2,421,360 QoQ

Shares Held

124,801

+37.1% QoQ

Ownership

0.668%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#23

of 156 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,647,082,401 across 216 Biotechnology names. RIGL ranks #82 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,126,080	$702,155,918
2	INCY	Incyte Corp	5,320,901	$603,177,333
3	EXEL	Exelixis, Inc.	11,023,943	$599,812,735
4	JAZZ	Jazz Pharmaceuticals plc	1,522,568	$366,893,205
5	BMRN	Biomarin Pharmaceutical Inc	5,699,541	$326,127,732
6	VRTX	Vertex Pharmaceuticals Inc / Ma	616,170	$306,070,117
7	RVMD	Revolution Medicines, Inc.	1,295,450	$242,611,869
8	RPRX	Royalty Pharma plc	4,305,412	$241,404,446

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,882,213	124,801	+37.1%	Shares	Defined	2026-08-14
2026-03-31	$2,460,853	91,008	-17.1%	Shares	Other	2026-05-15
2025-12-31	$4,699,990	109,736	+93.9%	Shares	Defined	2026-02-17
2025-09-30	$1,603,504	56,601	+463.9%	Shares	Other	2025-11-14
2025-06-30	$188,008	10,038	-5.5%	Shares	Other	2025-08-14
2025-03-31	$191,158	10,626	-65.8%	Shares	Other	2025-05-15
2022-03-31	$93,003	31,105	-32.4%	Shares	Defined	2022-05-16
2021-12-31	$121,870	45,989	0.0%	Shares	Defined	2022-02-14
2021-09-30	$166,940	45,989	0.0%	Shares	Defined	2021-11-15
2021-06-30	$199,592	45,989	0.0%	Shares	Defined	2021-08-16
2021-03-31	$157,282	45,989	-7.0%	Shares	Defined	2021-05-17
2020-12-31	$173,043	49,441	+104.0%	Shares	Defined	2021-02-16
2020-09-30	$58,168	24,237	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.